Back to today’s briefing

Story perspectives

Study Links Ozempic to Doubled Risk of Blindness

6/6/2025

45 10

Summary

Ozempic Eye Risks

A groundbreaking study reveals a troubling connection between Ozempic, a popular diabetes medication, and severe eye conditions like neovascular age-related macular degeneration (nAMD), a leading cause of blindness. Patients using Ozempic face double the risk of developing nAMD, prompting experts to call for urgent research into these alarming findings as reports of vision loss rise.

Summary

GLP-1 Eye Concerns

Recent studies reveal a troubling link between GLP-1 receptor agonist drugs, commonly prescribed for diabetes and weight loss, and a heightened risk of severe eye conditions. Patients may face increased chances of diabetic retinopathy and age-related macular degeneration. Researchers urge deeper exploration into these alarming side effects and their underlying causes.

1 of 2

Ozempic Eye Risks

A groundbreaking study reveals a troubling connection between Ozempic, a popular diabetes medication, and severe eye conditions like neovascular age-related macular degeneration (nAMD), a leading cause of blindness. Patients using Ozempic face double the risk of developing nAMD, prompting experts to call for urgent research into these alarming findings as reports of vision loss rise.

1 / 2